Galapagos NV
-0.24% €25.14
17:30 – 26/07/2024Nieuws van Galapagos NV
Galapagos (NASDAQ:GLPG) Stock Crosses Below 200 Day Moving Average of $31.79
Bron: ETF Daily News
Autheur: MarketBeat News
Gepubliceerd op: 2024-07-23
Galapagos NV (NASDAQ:GLPG – Get Free Report) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $31.79 and traded as low as $26.39. Galapagos shares last traded at $27.23, with a volum…
Galapagos (NASDAQ:GLPG) Sees Large Volume Increase
Bron: ETF Daily News
Autheur: MarketBeat News
Gepubliceerd op: 2024-07-15
Galapagos NV (NASDAQ:GLPG – Get Free Report) shares saw unusually-high trading volume on Monday . Approximately 44,078 shares changed hands during trading, a decline of 64% from the previous session’s volume of 123,442 shares.The stock last traded at $26.78 a…
Reviewing Galapagos (NASDAQ:GLPG) and Acerus Pharmaceuticals (OTCMKTS:ASPCF)
Bron: ETF Daily News
Autheur: MarketBeat News
Gepubliceerd op: 2024-07-17
Galapagos (NASDAQ:GLPG – Get Free Report) and Acerus Pharmaceuticals (OTCMKTS:ASPCF – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analys…
Head to Head Analysis: Zura Bio (NASDAQ:ZURA) and Gilead Sciences (NASDAQ:GILD)
Bron: ETF Daily News
Autheur: MarketBeat News
Gepubliceerd op: 2024-07-12
Zura Bio (NASDAQ:ZURA – Get Free Report) and Gilead Sciences (NASDAQ:GILD – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, …
Osteoporosis Market Drug Forecast and Analysis Research 2024: A $17.9 Billion Industry by 2033 – Focus on US, France, Germany, Italy, Spain, UK, Japan
Bron: GlobeNewswire
Autheur: Research and Markets
Gepubliceerd op: 2024-07-19
Dublin, July 19, 2024 (GLOBE NEWSWIRE) — The “Osteoporosis: Seven-Market Drug Forecast and Market Analysis” report has been added to ResearchAndMarkets.com’s offering.This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an E…
Cystic Fibrosis Market is Projected to Boost by 2034, Predicts DelveInsight | Key Companies – Verona Pharmaceuticals, Vertex Pharmaceuticals, Krystal Biotech, Aridis Pharmaceuticals, BiomX, Inc., Boehringer Ingelheim
Bron: GlobeNewswire
Autheur: DelveInsight Business Research LLP
Gepubliceerd op: 2024-07-11
According to DelveInsight’s analysis, the market for cystic fibrosis is anticipated to increase during the forecast period (2024–2034), owing to the launch of emerging therapies and healthcare spending. According to DelveInsight’s analysis, the market for cys…
Pagina’s
Social Media
AEX
- Shell PLC
- Nationale-Nederlanden
- Koninklijke Ahold Delhaize NV
- ASR Nederland NV
- Akzo Nobel NV
- AEGON N.V.
- Adyen NV
- Wolters Kluwer NV
- ArcelorMittal SA
- ASML Holding NV
- ABN Amro Bank NV
- DSM-Firmenich AG
- ING Groep NV
- Imcd NV
- RELX PLC
- Heineken N.V.
- Unilever plc
- Koninklijke Philips NV
- Prosus NV
- ASM International NV
- Koninklijke KPN N.V.
- Randstad NV
- BE Semiconductor Industries
- EXOR NV
- UMG
AMX
- Just Eat Takeaway.com NV
- Galapagos NV
- AALBERTS NV
- Advanced Metallurgical Group
- Air France-KLM
- Alfen N.V.
- ALLFUNDS GROUP
- Aperam
- Arcadis
- Basic-Fit
- Corbion
- CTP
- Eurocommercial Properties
- Fagron
- Flow Traders
- Fugro
- INPOST
- JDE PEET’S
- OCI
- SBM Offshore
- SIGNIFY NV
- TKH Group
- Van Lanschot Kempen NV
- Vopak Koninklijke
- WDP
AScX
- Accsys Technologies
- ACOMO
- Avantium
- AZERION
- BS Group SA
- BAM Groep Koninklijke
- Brunel International
- CM.COM
- EBUSCO HOLDING
- FASTNED
- ForFarmers
- Heijmans
- Kendrion
- Nedap N.V.
- NSI
- Pharming Group
- PostNL Koninklijke
- Sif Holding
- Sligro Food Group
- TomTom
- Vastned
- VIVORYON THERAPEUTICS N.V.
- Wereldhave
- Renewi plc
- Lucas Bols
Gemaakt door beleggers voor beleggers